Multi-analyte profiling reveals matrix metalloproteinase-9 and monocyte chemotactic protein-1 as plasma biomarkers of cardiac aging

Circulation: Cardiovascular Genetics

Volumn 4, Issue 4, 2011, Pages 455-462

  Chiao, Ying Ann ^a   Dai, Qiuxia ^a   Zhang, Jianhua ^a   Lin, Jing ^a   Lopez, Elizabeth F ^a   Ahuja, Seema S ^b   Chou, Youn Min ^b,c   Lindsey, Merry L ^a   Jin, Yu Fang ^d  

^a Mays Cancer Center at UT Health San Antonio   (United States)

^b UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^c UNIVERSITY OF TEXAS AT SAN ANTONIO   (United States)

^d The University of Texas at San Antonio   (United States)

Author keywords

Aging; Biomarker; Macrophage; Metalloproteinase; Myocardium

Indexed keywords

BIOLOGICAL MARKER; GELATINASE B; GRANULOCYTE CHEMOTACTIC PROTEIN 2; HAPTOGLOBIN; IMMUNOGLOBULIN A; MACROPHAGE INFLAMMATORY PROTEIN 2; MONOCYTE CHEMOTACTIC PROTEIN 1; MONOCYTE CHEMOTACTIC PROTEIN 5; MYELOPEROXIDASE; OSTEOPONTIN; STEM CELL FACTOR; TISSUE INHIBITOR OF METALLOPROTEINASE 1; VASCULAR CELL ADHESION MOLECULE 1;

AGED; ANIMAL TISSUE; ARTICLE; BLOOD LEVEL; BLOOD SAMPLING; CARDIAC AGING; CARDIOVASCULAR FUNCTION; CARDIOVASCULAR PARAMETERS; CELL DENSITY; CONCENTRATION (PARAMETERS); CONTROLLED STUDY; DIAGNOSTIC VALUE; DIASTOLE; ECHOCARDIOGRAPHY; END DIASTOLIC DIMENSION; END SYSTOLIC DIMENSION; FEMALE; HEART LEFT VENTRICLE; IMMUNOBLOTTING; IMMUNOHISTOCHEMISTRY; INFLAMMATION; MACROPHAGE; MACROPHAGE FUNCTION; MALE; MOUSE; MULTI ANALYTE PROFILING; NONHUMAN; PHENOTYPE; PLASMA; POSTERIOR WALL THICKNESS; PRIORITY JOURNAL; PROTEIN ANALYSIS; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; SENESCENCE;

AGING; ANIMALS; BIOLOGICAL MARKERS; CHEMOKINE CCL2; HEART; HEART VENTRICLES; INFLAMMATION; MACROPHAGES; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL;

MUS;

EID: 80052727564     PISSN: 1942325X     EISSN: 19423268     Source Type: Journal    
DOI: 10.1161/CIRCGENETICS.111.959981     Document Type: Article

References (35)

1. Cheitlin MD. Cardiovascular physiology-changes with aging. Am J Geriatr Cardiol. 2003;12:9-13.
2. Ferrari AU. Modifications of the cardiovascular system with aging. Am J Geriatr Cardiol. 2002;11:30-33.
3. Yang XS, Willems JL, Pardaens J, De Geest H. Acute myocardial infarction in the very elderly: a comparison with younger age groups. Acta Cardiol. 1987;42:59-68.
4. Gould KE, Taffet GE, Michael LH, Christie RM, Konkol DL, Pocius JS, Zachariah JP, Chaupin DF, Daniel SL, Sandusky GE Jr, Hartley CJ, Entman ML. Heart failure and greater infarct expansion in middle-aged mice: a relevant model for postinfarction failure. Am J Physiol Heart Circ Physiol. 2002;282:H615-H621. (Pubitemid 34654986)
5. Yip H-K, Wu C-J, Chang H-W, Wang C-P, Cheng C-I, Chua S, Chen M-C. Cardiac rupture complicating acute myocardial infarction in the direct percutaneous coronary intervention reperfusion era. Chest. 2003; 124:565-571. (Pubitemid 37000135)
6. Lin J, Lopez EF, Jin Y, Van Remmen H, Bauch T, Han HC, Lindsey ML. Age-related cardiac muscle sarcopenia: combining experimental and mathematical modeling to identify mechanisms. Exp Gerontol. 2008;43: 296-306.
7. Marom B, Rahat MA, Lahat N, Weiss-Cerem L, Kinarty A, Bitterman H. Native and fragmented fibronectin oppositely modulate monocyte secretion of MMP-9. J Leukoc Biol. 2007;81:1466-1476. (Pubitemid 46827969)
8. Okada Y, Gonoji Y, Naka K, Tomita K, Nakanishi I, Iwata K, Yamashita K, Hayakawa T. Matrix metalloproteinase 9 (92-kda gelatinase/type IV collagenase) from HT 1080 human fibrosarcoma cells. J Biol Chem. 1992;267:21712-21719.
9. Cauwe B, Steen PEVd, Opdenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol. 2007;42:113-185. (Pubitemid 46911962)
10. Egeblad M, Werb Z. New functions for the matrix metalloproteinases in cancer progression. Nat Rev Cancer. 2002;2:163-176.
11. Ducharme A, Frantz S, Aikawa M, Rabkin E, Lindsey M, Rohde LE, Schoen FJ, Kelly RA, Werb Z, Libby P, Lee RT. Targeted deletion of matrix metalloproteinase-9 attenuates left ventricular enlargement and collagen accumulation after experimental myocardial infarction. J Clin Invest. 2000;106:55-62. (Pubitemid 30437240)
12. Squire IB, Evans J, Ng LL, Loftus IM, Thompson MM. Plasma MMP-9 and MMP-2 after acute myocardial infarction in man: correlation with echocardiographic and neurohumoral parameters of left ventricular dysfunction. J Card Fail. 2004;10:328-333. (Pubitemid 39092685)
13. Blankenberg S, Rupprecht HJ, Poirier O, Bickel C, Smieja M, Hafner G, Meyer J, Cambien F, Tiret L, for the AtheroGene Investigators. Plasma concentrations and genetic variation of matrix metalloproteinase 9 and prognosis of patients with cardiovascular disease. Circulation. 2003;107: 1579-1585. (Pubitemid 36397324)
14. Lindsey ML, Goshorn DK, Squires CE, Escobar GP, Hendrick JW, Mingoia JT, Sweterlitsch SE, Spinale FG. Age-dependent changes in myocardial matrix metalloproteinase/tissue inhibitor of metalloproteinase profiles and fibroblast function. Cardiovasc Res. 2005;66:410-419. (Pubitemid 40471056)
15. de Lemos JA, Morrow DA, Blazing MA, Jarolim P, Wiviott SD, Sabatine MS, Califf RM, Braunwald E. Serial measurement of monocyte chemoattractant protein-1 after acute coronary syndromes: results from the A to Z Trial. J Am Coll Cardiol. 2007;50:2117-2124. (Pubitemid 350117348)
16. de Lemos JA, Morrow DA, Sabatine MS, Murphy SA, Gibson CM, Antman EM, McCabe CH, Cannon CP, Braunwald E. Association between plasma levels of monocyte chemoattractant protein-1 and long-term clinical outcomes in patients with acute coronary syndromes. Circulation. 2003;107:690-695. (Pubitemid 36222595)
17. Gonzalez-Quesada C, Frangogiannis NG. Monocyte chemoattractant protein- 1/CCl2 as a biomarker in acute coronary syndromes. Curr Atheroscler Rep. 2009;11:131-138.
18. Kervinen H, Manttari M, Kaartinen M, Makynen H, Palosuo T, Pulkki K, Kovanen PT. Prognostic usefulness of plasma monocyte/macrophage and T-lymphocyte activation markers in patients with acute coronary syndromes. Am J Cardiol. 2004;94:993-996. (Pubitemid 39336429)
19. Inadera H, Egashira K, Takemoto M, Ouchi Y, Matsushima K. Increase in circulating levels of monocyte chemoattractant protein-1 with aging. J Interferon Cytokine Res. 1999;19:1179-1182. (Pubitemid 29502785)
20. Polansky AM, Chou Y, Mason RL. An algorithm for fitting Johnson transformations to non-normal data. J Qual Technol. 1999;31:345-350.
21. Rosenberg M, Zugck C, Nelles M, Juenger C, Frank D, Remppis A, Giannitsis E, Katus HA, Frey N. Osteopontin, a new prognostic biomarker in patients with chronic heart failure. Circ Heart Fail. 2008;1: 43-49.
22. Sundstrom J, Evans JC, Benjamin EJ, Levy D, Larson MG, Sawyer DB, Siwik DA, Colucci WS, Wilson PW, Vasan RS. Relations of plasma total timp-1 levels to cardiovascular risk factors and echocardiographic measures: the Framingham Heart Study. Eur Heart J. 2004;25:1509-1516. (Pubitemid 39165629)
23. Kelly D, Squire IB, Khan SQ, Dhillon O, Narayan H, Ng KH, Quinn P, Davies JE, Ng LL. Usefulness of plasma tissue inhibitors of metalloproteinases as markers of prognosis after acute myocardial infarction. Am J Cardiol. 2010;106:477-482.
24. Mishto M, Santoro A, Bellavista E, Bonafe M, Monti D, Franceschi C. Immunoproteasomes and immunosenescence. Ageing Res Rev. 2003;2: 419-432. (Pubitemid 37159402)
25. Franceschi C. Inflammaging as a major characteristic of old people: can it be prevented or cured? Nutr Rev. 2007;65:S173-S176.
26. Cheng XW, Kuzuya M, Nakamura K, Maeda K, Tsuzuki M, Kim W, Sasaki T, Liu Z, Inoue N, Kondo T, Jin H, Numaguchi Y, Okumura K, Yokota M, Iguchi A, Murohara T. Mechanisms underlying the impairment of ischemia-induced neovascularization in matrix metalloproteinase 2-deficient mice. Circ Res. 2007;100:904-913. (Pubitemid 46555696)
27. Reed MJ, Corsa AC, Kudravi SA, McCormick RS, Arthur WT. A deficit in collagenase activity contributes to impaired migration of aged microvascular endothelial cells. J Cel Biochem. 2000;77:116-126. (Pubitemid 30126900)
28. Cheng XW, Kuzuya M, Kim W, Song H, Hu L, Inoue A, Nakamura K, Di Q, Sasaki T, Tsuzuki M, Shi GP, Okumura K, Murohara T. Exercise training stimulates ischemia-induced neovascularization via phosphatidylinositol 3-kinase/akt-dependent hypoxia-induced factor-1 alpha reactivation in mice of advanced age. Circulation. 2010;122:707-716.
29. Nossuli TO, Frangogiannis NG, Knuefermann P, Lakshminarayanan V, Dewald O, Evans AJ, Peschon J, Mann DL, Michael LH, Entman ML. Brief murine myocardial I/R induces chemokines in a TNF-alphaindependent manner: role of oxygen radicals. Am J Physiol Heart Circ Physiol. 2001;281:H2549-H2558.
30. Parissis JT. Serum profiles of C-C chemokines in acute myocardial infarction: possible implication in postinfarction left ventricular remodeling. J Interferon Cytokine Res. 2002;22:223-229. (Pubitemid 34275490)
31. Aukrust P. Elevated circulating levels of C-C chemokines in patients with congestive heart failure. Circulation. 1998;97:1136-1143. (Pubitemid 28152886)
32. Chen J, Mo R, Lescure PA, Misek DE, Hanash S, Rochford R, Hobbs M, Yung RL. Aging is associated with increased t-cell chemokine expression in c57bl/6 mice. J Gerontol A Biol Sci Med Sci. 2003;58:B975-B983.
33. Felzien LK, McDonald JT, Gleason SM, Berman NE, Klein RM. Increased chemokine gene expression during aging in the murine brain. Brain Res. 2001;890:137-146. (Pubitemid 32119533)
34. Mello Coelho V, Bunbury A, Rangel LB, Giri B, Weeraratna A, Morin PJ, Bernier M, Taub DD. Fat-storing multilocular cells expressing ccr5 increase in the thymus with advancing age: potential role for ccr5 ligands on the differentiation and migration of preadipocytes. Int J Med Sci. 2009;7:1-14.
35. Huang K, Mitzner W, Rabold R, Schofield B, Lee H, Biswal S, Tankersley CG. Variation in senescent-dependent lung changes in inbred mouse strains. J Appl Physiol. 2007;102:1632-1639. (Pubitemid 46571061)